and/or production of multiple different forms of IGF-I (5). However, the mechanisms affected by the IGF-I have resulted in some controversy among various labs (10) . Here, provocative data from Barton et al. (2) demonstrate that matrix metalloproteinase 13 (MMP-13) was found to be sensitive to both forms of IGF-I. MMPs are known to be critical for remodeling of the extracellular matrix (ECM), which includes collagen function. Kjaer's lab (7) has demonstrated alterations in collagen gene expression occur within muscle and tendon with increased mechanical loading of muscle. Further, MMP activation increases with mechanical load and concurrently with alterations in collagen tissue dynamics (6) . Thus, when one considers that there is ECM located in the peri-and intramuscular regions of muscle, it should be expected that a dynamic interaction would exist between muscle and its surrounding connective tissue that would likely lead to cross talk among the tissue. Thus it is not unreasonable to suggest that the elevations in IGF-I production by the muscle during mechanical loading may be affecting collagen dynamics in a paracrine fashion. Indeed, Doessing et al. (3) recently suggested that the increased IGF-I seen after exogenous growth hormone administration is affecting collagen synthesis in muscle and tendon but not affecting fractional protein synthesis in muscle. So, perhaps the role of increased IGF-I expression with mechanical loading is to mediate changes with ECM, which is adapting concurrently with muscle hypertrophy.
Another elusive fact of the different isoforms of IGF-I is the upstream mechanism of action, in that it has been unclear if the different forms of IGF-I utilize the same membrane-based receptor. For example, previous suggestions were made that MGF (i.e., IGF-I IB or IC) affected mechanisms that regulate skeletal muscle mass through means independent of the known IGF-I receptor (11). Barton et al. (2) address this issue by employing the MKR mouse, which is a transgenic mouse that expresses a dominant negative IGF-I receptor specifically in skeletal muscle. The skeletal muscle of the MKR mouse does not respond to exogenous or endogenous IGF-I (9). Here, Barton et al. (2) clearly demonstrate that IGF-I IA or IB (i.e., MGF) overexpression cannot increase muscle mass without a functional IGF-I receptor. These data indicate that in order for exogenous MGF to induced muscle hypertrophy it does in fact require a functional IGF-I receptor. However, surprisingly both forms of IGF-I were able to induce changes in mRNA expression without a functioning IGF-I receptor; however, at this time it is unclear if the source of the signal was actually the muscle or other nonmuscle cells that reside in the muscle (i.e., fibroblasts).
Thus, by using a combination of sophisticated molecular tools, Barton et al. (2) have provided us with a substantial amount of knowledge that perhaps sheds light on the effects of increased IGF-I during mechanical loading and its role in muscle hypertrophy. Further, the data indicate that isoforms of IGF-I mediate the majority of their effects through the IGF-I receptor, in particular the ability to induce muscle hypertrophy when the IGF-I is delivered exogenously. Overall, these find-ings have provided muscle biologists with novel data that should help push forward our understanding of the role of IGF-I in skeletal muscle biology and lead us to more conclusive findings about mechanisms that are activated by the different endogenous forms of IGF-I during mechanical loading.
